• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院环境中的药剂师与避孕

Pharmacists and Contraception in the Inpatient Setting.

作者信息

Ciriello Domenique, Cieri-Hutcherson Nicole

机构信息

Kaleida Health/Buffalo General Medical Center, Buffalo, NY 14203, USA.

School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14260, USA.

出版信息

Pharmacy (Basel). 2020 May 9;8(2):82. doi: 10.3390/pharmacy8020082.

DOI:10.3390/pharmacy8020082
PMID:32397460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7356798/
Abstract

The choice of contraceptive method should be based on patient specific factors, patient preference, and method-specific properties. In this article, we review opportunities for an inpatient clinical pharmacist to assist in the selection and counseling of contraceptives in hospitalized patients. An inpatient pharmacist has the opportunity to discuss various contraceptive methods with the patient, ensuring an appropriate method is used after discharge, which is especially important after the occurrence of a contraception-related adverse effect or contraindication to certain contraceptive methods. Barriers, such as formulary restrictions, can limit inpatient initiation of contraceptive therapy while hospitalized, but pharmacists can provide education on appropriate alternatives. Inpatient clinical pharmacists can also make recommendations for contraceptive methods in special populations. It is crucial to select an appropriate therapy in patients with an underlying medical condition, such as those with active or history of breast cancer, psychiatric disorder, or thrombophilia, as inappropriate therapy can cause an increased risk of harm. Pharmacists can assist in contraceptive counseling, evaluating for drug-drug and drug-disease interactions, and recommending the most appropriate therapy in special populations. An inpatient pharmacist has the opportunity to interact with the medical team and assist in navigation of teratogenic medication use and Risk Evaluation and Mitigation Strategies.

摘要

避孕方法的选择应基于患者的具体因素、患者偏好以及方法的特定属性。在本文中,我们回顾了住院临床药师在协助住院患者选择和咨询避孕方法方面的机会。住院药师有机会与患者讨论各种避孕方法,确保出院后使用合适的方法,这在发生与避孕相关的不良反应或对某些避孕方法有禁忌证后尤为重要。诸如处方集限制等障碍可能会限制住院期间避孕治疗的起始,但药师可以提供关于合适替代方法的教育。住院临床药师还可以针对特殊人群的避孕方法提出建议。在患有基础疾病的患者中选择合适的治疗方法至关重要,例如那些患有乳腺癌、精神疾病或血栓形成倾向的患者,因为不适当的治疗可能会增加伤害风险。药师可以协助进行避孕咨询,评估药物相互作用和药物与疾病的相互作用,并为特殊人群推荐最合适的治疗方法。住院药师有机会与医疗团队互动,并协助处理致畸药物的使用以及风险评估和缓解策略。

相似文献

1
Pharmacists and Contraception in the Inpatient Setting.住院环境中的药剂师与避孕
Pharmacy (Basel). 2020 May 9;8(2):82. doi: 10.3390/pharmacy8020082.
2
Counseling on contraceptives: an unfilled need.
Am Pharm. 1985 Sep;NS25(9):42-6. doi: 10.1016/s0160-3450(16)32832-x.
3
Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.有癫痫的育龄女性使用致畸药物及同时使用避孕药的情况。
Epilepsy Behav. 2015 Nov;52(Pt A):212-7. doi: 10.1016/j.yebeh.2015.08.004. Epub 2015 Nov 6.
4
Community pharmacists and improving contraception access: Relationships between contraceptive counseling and dispensing contraceptives.
Res Social Adm Pharm. 2023 Dec;19(12):1602-1605. doi: 10.1016/j.sapharm.2023.09.004. Epub 2023 Sep 11.
5
Ensuring optimal insulin utilization in the hospital setting: role of the pharmacist.确保医院环境中胰岛素的最佳利用:药剂师的作用。
Am J Health Syst Pharm. 2010 Aug;67(16 Suppl 8):S9-16. doi: 10.2146/ajhp100172.
6
Canadian Contraception Consensus (Part 1 of 4).加拿大避孕共识(共4部分,第1部分)
J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0.
7
Canadian Contraception Consensus (Part 2 of 4).加拿大避孕共识(共四部分,第二部分)
J Obstet Gynaecol Can. 2015 Nov;37(11):1033-9. doi: 10.1016/s1701-2163(16)30054-8.
8
An Innovative Framework to Improve Teratogenic Medication Risk Counseling.一种改善致畸药物风险咨询的创新框架。
J Midwifery Womens Health. 2017 May;62(3):353-357. doi: 10.1111/jmwh.12604. Epub 2017 May 9.
9
New IPPF statement on breastfeeding, fertility and post-partum contraception.国际计划生育联合会关于母乳喂养、生育力和产后避孕的新声明。
IPPF Med Bull. 1990 Apr;24(2):2-4.
10
Contraception for Adolescents and Young Adults in the Inpatient Setting: The Providers' Perspective.住院环境下青少年及青年成人的避孕问题:提供者视角
Hosp Pediatr. 2018 Apr;8(4):194-199. doi: 10.1542/hpeds.2017-0167. Epub 2018 Mar 1.

引用本文的文献

1
A Call for Equal and Equitable Reproductive Health Care Access, Including the Provision of Accurate Education to Pediatric Patients.呼吁提供平等且公平的生殖健康护理服务,包括为儿科患者提供准确的教育。
J Pediatr Pharmacol Ther. 2025 Apr;30(2):271-281. doi: 10.5863/1551-6776-30.2.271. Epub 2025 Apr 14.
2
Contraceptive use and counselling in women with mental illness: KwaZulu-Natal, South Africa.南非夸祖鲁 - 纳塔尔省:患有精神疾病女性的避孕措施使用情况及咨询服务
S Afr J Psychiatr. 2025 Jun 4;31:2397. doi: 10.4102/sajpsychiatry.v31i0.2397. eCollection 2025.

本文引用的文献

1
Risks of using SSRI / SNRI antidepressants during pregnancy and lactation.孕期及哺乳期使用选择性5-羟色胺再摄取抑制剂/5-羟色胺-去甲肾上腺素再摄取抑制剂类抗抑郁药的风险。
Interdiscip Toxicol. 2017 Sep;10(1):30-34. doi: 10.1515/intox-2017-0004.
2
Medications and pregnancy: The role of community pharmacists - A descriptive study.药物与妊娠:社区药剂师的作用——一项描述性研究。
PLoS One. 2018 May 9;13(5):e0195101. doi: 10.1371/journal.pone.0195101. eCollection 2018.
3
Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.联合避孕药类型、因子 V 莱顿突变与静脉血栓栓塞风险。
Thromb Haemost. 2018 May;118(5):922-928. doi: 10.1055/s-0038-1641152. Epub 2018 Apr 3.
4
Contemporary Hormonal Contraception and the Risk of Breast Cancer.当代激素避孕与乳腺癌风险。
N Engl J Med. 2017 Dec 7;377(23):2228-2239. doi: 10.1056/NEJMoa1700732.
5
Inpatient Postpartum Long-Acting Reversible Contraception: Care That Promotes Reproductive Justice.住院产后长效可逆避孕:促进生殖公正的护理
Obstet Gynecol. 2017 Oct;130(4):783-787. doi: 10.1097/AOG.0000000000002262.
6
Combined hormonal contraception and the risk of venous thromboembolism: a guideline.联合激素避孕与静脉血栓栓塞风险:指南。
Fertil Steril. 2017 Jan;107(1):43-51. doi: 10.1016/j.fertnstert.2016.09.027. Epub 2016 Oct 25.
7
Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.非口服复方激素避孕药与血栓栓塞:一项系统评价
Contraception. 2017 Feb;95(2):130-139. doi: 10.1016/j.contraception.2016.10.005. Epub 2016 Oct 19.
8
Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception.委员会意见第 670 号:产后即刻长效可逆避孕。
Obstet Gynecol. 2016 Aug;128(2):e32-7. doi: 10.1097/AOG.0000000000001587.
9
Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review.患有抑郁症和双相情感障碍的女性使用激素避孕法和宫内节育器的安全性:一项系统评价
Contraception. 2016 Dec;94(6):641-649. doi: 10.1016/j.contraception.2016.06.012. Epub 2016 Jun 27.
10
Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: Evidence or hope-based tool ?通过基因检测识别使用避孕药有静脉血栓栓塞风险的女性:基于证据还是基于希望的工具?
Swiss Med Wkly. 2016 Jun 1;146:w14321. doi: 10.4414/smw.2016.14321. eCollection 2016.